Gräfe Willy, Scheibe Sandy, Schwarz Josy, Liebig Lukas, Voigt Karen, Schübel Jeannine
Department of General Practice, Faculty of Medicine Carl Gustav Carus, Dresden University of Technology, Dresden, Saxony, Germany.
J Endocrinol Invest. 2025 May 28. doi: 10.1007/s40618-025-02606-4.
Iodine is an essential trace element for thyroid hormone synthesis, and its role in thyroid health has been widely studied. While iodine deficiency is recognized as a risk factor for goiter, its association with thyroid nodules remains controversial. The aim of this systematic review and meta-analysis was to evaluate the relationship between iodine intake and the development of thyroid nodules.
A systematic literature search was conducted in Medline (via PubMed), the Cochrane Library, and guideline registries (AWMF, GIN) for studies published between 2012 and 2023. Inclusion criteria focused on studies examining the association between iodine intake and thyroid nodule. Systematic review has been conducted whereas study quality was assessed using the checklists of Critical Appraisal Skills Programme (CASP). A meta-analysis was performed for studies reporting odds ratios based on WHO-defined iodine categories.
A total of 31 studies were included. Most studies (n = 23) were cross-sectional, limiting causal conclusions. The most used method for assessing iodine intake was urinary iodine concentration (UIC), though measurement approaches varied. N = 10 studies compared median UIC between groups with and without thyroid nodules, with n = 8 reporting significant differences. However, the iodine levels in both groups often remained within the WHO-defined adequate iodine range. N = 8 studies examined odds ratios for iodine intake and thyroid nodule risk, with n = 5 identifying iodine deficiency (< 100 μg/L) as a significant risk factor. However, results for more than adequate (> 200 μg/L) and excessive iodine intake (> 300 μg/L) were inconsistent. N = 3 studies suggested a U-shaped relationship between iodine and thyroid nodule prevalence, but meta-analysis findings did not confirm this hypothesis. The pooled odds ratio for iodine deficiency was 1.24 (95% CI [1.16-1.33], I = 0.00), while more than adequate and excessive iodine intake showed no significant association.
This systematic review and meta-analysis indicate that iodine deficiency increases moderately the risk of developing thyroid nodules, while more than adequate and excessive iodine intake does not show a consistent effect. However, the heterogeneity of study results and the predominance of cross-sectional designs limit definitive conclusions. Further prospective studies are needed to clarify the causal relationship between iodine intake and thyroid nodules.
碘是甲状腺激素合成所必需的微量元素,其在甲状腺健康中的作用已得到广泛研究。虽然碘缺乏被认为是甲状腺肿大的一个危险因素,但其与甲状腺结节的关联仍存在争议。本系统评价和荟萃分析的目的是评估碘摄入量与甲状腺结节发生之间的关系。
在Medline(通过PubMed)、Cochrane图书馆和指南注册库(AWMF、GIN)中对2012年至2023年发表的研究进行了系统的文献检索。纳入标准侧重于研究碘摄入量与甲状腺结节之间的关联。进行了系统评价,同时使用批判性评估技能计划(CASP)清单评估研究质量。对根据世界卫生组织定义的碘类别报告比值比的研究进行了荟萃分析。
共纳入31项研究。大多数研究(n = 23)为横断面研究,限制了因果结论。评估碘摄入量最常用的方法是尿碘浓度(UIC),尽管测量方法各不相同。10项研究比较了有甲状腺结节和无甲状腺结节组之间的UIC中位数,8项报告有显著差异。然而,两组的碘水平通常仍处于世界卫生组织定义的适宜碘范围内。8项研究检查了碘摄入量与甲状腺结节风险的比值比,5项确定碘缺乏(<100μg/L)是一个显著的危险因素。然而,碘摄入量超过适宜水平(>200μg/L)和过量摄入碘(>300μg/L)的结果并不一致。3项研究表明碘与甲状腺结节患病率之间呈U形关系,但荟萃分析结果并未证实这一假设。碘缺乏的合并比值比为1.24(95%CI[1.16 - 1.33],I² = 0.00),而碘摄入量超过适宜水平和过量摄入碘均未显示出显著关联。
本系统评价和荟萃分析表明,碘缺乏会适度增加患甲状腺结节的风险,而碘摄入量超过适宜水平和过量摄入碘并未显示出一致的影响。然而,研究结果的异质性和横断面设计的主导性限制了确定性结论。需要进一步的前瞻性研究来阐明碘摄入量与甲状腺结节之间的因果关系。